| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/05/2011 | EP2270213A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270212A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270211A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270210A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270201A1 Detection of unhealthy cell and uses thereof |
| 01/05/2011 | EP2270199A1 Method of pretreating sample for measurement of glycated amine and method of measuring glycated amine |
| 01/05/2011 | EP2270196A2 Assay for drug discovery based on in vitro differentiated cells |
| 01/05/2011 | EP2270177A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270176A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270175A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270171A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 01/05/2011 | EP2270170A1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 01/05/2011 | EP2270160A1 Methods for identification, and compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/05/2011 | EP2270158A2 Bitter taste receptors |
| 01/05/2011 | EP2270157A2 Bitter taste receptors |
| 01/05/2011 | EP2270156A2 Bitter taste receptors |
| 01/05/2011 | EP2270155A2 Bitter taste receptors |
| 01/05/2011 | EP2270154A2 Bitter taste receptors |
| 01/05/2011 | EP2270153A2 Bitter taste receptors |
| 01/05/2011 | EP2270150A2 Method for controlling the activity of immunologically functional molecule |
| 01/05/2011 | EP2270149A2 Method for controlling the activity of immunologically functional molecule |
| 01/05/2011 | EP2270148A2 Method for controlling the activity of immunologically functional molecule |
| 01/05/2011 | EP2270147A2 Method for controlling the activity of immunologically functional molecule |
| 01/05/2011 | EP2270145A1 Novel protein capable of binding to hyaluronic acid, and method for measurement of hyaluronic acid using the same |
| 01/05/2011 | EP2270126A1 Cell selection apparatus, and cell selection method using the same |
| 01/05/2011 | EP2270106A2 Indolium compounds containing fluoro-substituents |
| 01/05/2011 | EP2270105A1 Stabilizer for color developer and use thereof |
| 01/05/2011 | EP2270052A2 Antibodies to OPGL |
| 01/05/2011 | EP2270047A2 Anti-C5 antibodies and their therapeutic uses |
| 01/05/2011 | EP2270046A2 Methods and compositions for the treatment of hemolysis-associated diseases |
| 01/05/2011 | EP2270045A1 Antibodies against Clostridium difficile toxins and uses thereof |
| 01/05/2011 | EP2270040A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 01/05/2011 | EP2270032A2 Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeenis |
| 01/05/2011 | EP2270031A2 Heterologous expression of neisserial proteins |
| 01/05/2011 | EP2270028A1 Biomolecule-immobilized carrier and method for immobilizing biomolecule on carrier |
| 01/05/2011 | EP2269738A1 Device for thermo-dependent chain reaction amplification of target nucleic acid sequences |
| 01/05/2011 | EP2269735A1 Method for generating diffusion gradients |
| 01/05/2011 | EP2269724A1 Method for determining one or more analytes in complex biological samples and use of same |
| 01/05/2011 | EP2269636A2 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 01/05/2011 | EP2269634A2 Antigenic polypeptides |
| 01/05/2011 | EP2269628A2 Pancreas-specific proteins |
| 01/05/2011 | EP2269597A1 CLEC-2 is an essential platelet activating receptor in hemostasis and thrombosis |
| 01/05/2011 | EP2269076A1 Methods to determine susceptibility to treatment with leukotriene modifiers |
| 01/05/2011 | EP2269075A1 Method of detection and/or titration in vitro of an unconventional transmissible agent |
| 01/05/2011 | EP2269074A1 Methods for screening compounds for treating and/or preventing an hepatitis c virus infection |
| 01/05/2011 | EP2269073A1 A method of assessing cancer status in a breast cancer patient |
| 01/05/2011 | EP2269072A1 Predictive marker for topoisomerase i inhibitors |
| 01/05/2011 | EP2269071A1 Methods and agents for the diagnosis and treatment of hepatocellular carcinoma |
| 01/05/2011 | EP2269070A1 Dna repair proteins associated with triple negative breast cancers and methods of use thereof |
| 01/05/2011 | EP2269069A1 Use of synthetic peptide derived from zebra protein for the in vivo diagnosis of the epstein-barr virus (ebv) reactivation |
| 01/05/2011 | EP2269068A1 Method of assessing kidney function in a human subject |
| 01/05/2011 | EP2269067A1 Assay device comprising bubble-forming means |
| 01/05/2011 | EP2269066A1 Surface for label independent detection and method thereof |
| 01/05/2011 | EP2269065A2 Methods and reagents to increase the sensitivity of enzyme metallographic detection |
| 01/05/2011 | EP2269064A1 Protein labeling with cyanobenzothiazole conjugates |
| 01/05/2011 | EP2269063A2 Predicting risk of major adverse cardiac events |
| 01/05/2011 | EP2269062A2 Method for the diagnosis of higher- and lower-grade astrocytoma using biomarkers and diagnostic kit thereof |
| 01/05/2011 | EP2269061A2 System and method for testing heat exchange system for heat exchange catheter |
| 01/05/2011 | EP2269060A1 Copd biomarker signatures |
| 01/05/2011 | EP2269059A1 Method for monitoring thixotropy in concrete mixing drum |
| 01/05/2011 | EP2269058A1 Method for characterising the knock-resistance of fuels |
| 01/05/2011 | EP2269057A1 Detection of gaseous halogens |
| 01/05/2011 | EP2269050A1 Instrumentation and analytical techniques suitable for broadband acoustic resonance dissolution spectroscopy |
| 01/05/2011 | EP2269048A2 Electrochemical assay |
| 01/05/2011 | EP2269046A1 Electrochemical measurement system for the trace heavy metals in organic waste water |
| 01/05/2011 | EP2269038A2 Method and apparatus for analyzing individual cells or particulates using fluorescent quenching and/or bleaching |
| 01/05/2011 | EP2268837A1 Diagnosis of hereditary spastic paraplegias (hsp) by identification of a mutation in the zfyve26 gene or protein |
| 01/05/2011 | EP2268830A1 Peritoneal dialysis solution test method |
| 01/05/2011 | EP2268801A2 Compositions and processes relating to human bocavirus |
| 01/05/2011 | EP2268659A2 Mutant forms of chlamydia htra |
| 01/05/2011 | EP2268658A1 Peptides and aptamers thereof as specific modulators of mutant p53 function |
| 01/05/2011 | EP2268657A2 Histidine related compounds for identifying and blocking amyloid beta ion channels |
| 01/05/2011 | EP2268656A1 Fluorogenic peptides and their method of production |
| 01/05/2011 | EP2268321A1 Method of determining alanine transaminase (alt) activity by 13c-mr detection using hyperpolarised 13c-pyruvate |
| 01/05/2011 | EP2268317A2 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same |
| 01/05/2011 | EP2268305A2 Oxidized paraoxonase 1 and paraoxonase 1/hdl particle number ratio as risk markers for cardiovascular disease |
| 01/05/2011 | EP2268296A1 Compositions and method for the diagnosis, prevention and treament of alzeimer's disease |
| 01/05/2011 | EP2268135A2 Screening for non-genotoxic carcinogens |
| 01/05/2011 | EP2069385B1 Immobilization of membrane proteins onto supports via an amphiphile |
| 01/05/2011 | EP2026067B1 Method for detection of disease having insulin-resistant condition |
| 01/05/2011 | EP1981966B1 Use of human hepatocytes and in-vitro-process for determining liver function and liver regeneration |
| 01/05/2011 | EP1952293B1 Methods for the identification of microrna and their applications in research and human health |
| 01/05/2011 | EP1891434B1 Purification, characterization and reconstitution of a ubiquitin e3 ligase |
| 01/05/2011 | EP1875237B1 Docetaxel immunoassay |
| 01/05/2011 | EP1778869B1 Methods and devices for diagnosis of appendicitis |
| 01/05/2011 | EP1766398B1 Method for detecting molecular surface interactions |
| 01/05/2011 | EP1723417B1 C20orf23 as modifier of the igfr pathway and methods of use |
| 01/05/2011 | EP1682894B1 Methods relating to hepatitis b infection |
| 01/05/2011 | EP1619499B1 Novel screening method |
| 01/05/2011 | EP1619498B1 Method of screening remedy for heart disease and medicinal composition for treating heart disease |
| 01/05/2011 | EP1603941B1 Inhibitors of extracellular hsp90 |
| 01/05/2011 | EP1552272B1 Palladium-silver alloy nanowires and nanoparticle columns for use as variable-range hydrogen sensors |
| 01/05/2011 | EP1549336B1 Prevention and/or treatment of ulcerative colitis using pyy or pyy[3-36] |
| 01/05/2011 | EP1546182B1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/05/2011 | EP1493034B1 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1 immunoreactivity |
| 01/05/2011 | EP1485415B1 Neoplasm specific antibodies and uses thereof |
| 01/05/2011 | EP1463806B1 Novel cyclooxygenase variants and methods of use |
| 01/05/2011 | EP1453471B1 Expression vectors encoding epitopes of antigens and methods for their design |
| 01/05/2011 | EP1437043B1 Rat model with overexpression of regucalcin |
| 01/05/2011 | EP1417472B9 Process and apparatus for preparing and presenting a tissue sample for histological study |